Skip to main content

Table 2 Growth inhibitory effects of HepG2 human liver cancer cells by resveratrol and paclitaxel by an MTT

From: Resveratrol enhances anticancer effects of paclitaxel in HepG2 human liver cancer cells

Treatment OD570 value Inhibitory rate (%)
Control 0.431 ± 0.003a /
PA-L 0.322 ± 0.006b 25.3 ± 2.1d
Res + PA-L 0.287 ± 0.008c 33.4 ± 2.2c
PA-H 0.202 ± 0.008d 53.1 ± 2.3b
Res + PA-H 0.089 ± 0.005e 79.4 ± 1.9a
  1. PA-L 5 μg/mL of paclitaxel, Res + PA-L 10 μg/mL of resveratrol +5 μg/mL of paclitaxel, PA-H 10 μg/mL of paclitaxel, Res + PA-H 10 μg/mL of resveratrol +10 μg/mL of paclitaxel
  2. a-eMean values with different letters in the same column are significantly different (P < 0.05) according to Dunnett’s post-hoc test